Argus
•
Sep 01, 2026
GSK plc: Low P/E ratio and high yield
Summary
GSK plc, based in Brentford, UK, is a global healthcare company engaged in the discovery, development, manufacture, and marketing of pharmaceutical products. The company's leading products include treatments for asthma and COPD; treatments for HIV infection; and a range of
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Market Update: TEVA, ES, VMC
Sep 04, 2026
•
TEVA, VMC, ES
Analyst Report: Teva Pharm. Indtr. Ltd
Sep 04, 2026
•
TEVA
Analyst Report: Biogen Inc.
Sep 03, 2026
•
BIIB
Analyst Report: Medtronic plc
Sep 01, 2026
•
MDT
Analyst Report: The Procter & Gamble Company
Aug 31, 2026
•
PG
Analyst Profile
Jasper Hellweg
Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing. Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.
